Anesthesia Drugs Market to Surpass USD 1,530 Million by 2032

The global anesthesia drugs market was estimated at USD 460 million in 2022 and is projected to surpass around USD 1,530 million by 2032, expanding at a healthy CAGR of 13.3% from 2023 to 2032.

Ottawa, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The global anesthesia drugs market size accounted for USD 500 million in 2023 and is anticipated to reach around USD 1,120 million by 2030, according to a study published by Towards Healthcare a sister firm of Precedence Research. North America led the market with the largest market share of 58% in 2022.

Download a Short Version of this Report @

Anesthesia Provides Relief To Those Who Wish To Avoid Surgical Pain

Anesthesia is a medication that makes you unconscious during surgical procedures. Anesthetics are pain-relieving medications that help patients relax during surgeries. General anesthesia drugs, regional anesthesia, epidural, spinal, and nerve block anesthesia drugs, and combined general and epidural anesthesia are all examples of anesthesia. Each type of anesthesia prevents a specific type of pain sensation.

The Evolution Of Anesthesia

In the early 1840s, doctors first anesthetized patients by inhaling diethyl ether gases. It was used during surgeries despite its aftereffects of nausea and vomiting. Soon after, doctors were given the option of using nitrous oxide. It's still used today, but mostly as a driver for stronger inhaled anesthetics.

Ambulatory Anesthesia allows patients to leave the hospital earlier after recovering from anesthesia drugs, while also providing significant benefits to third-party payers, hospitals, healthcare providers, and patients. Furthermore, as general anesthesia drugs and techniques improve, as well as the wide availability of short-acting anesthetics with very few adverse effects, the number of ambulatory surgeries has increased exponentially.

You can place an order or ask any questions, please feel free to contact us at

Who Can Perform An Anesthetic Procedure?

A physician anesthesiologist will administer your anesthetic for more complex and invasive procedures. This medical professional will manage your pain before, during, and after surgery. Your anesthesia team may include physicians in training (fellows or residents), a Certified Registered Nurse Anesthetist (CRNA), or a Certified Anesthesiologist Assistant(CAA) in addition to your physician anesthesiologist.

Propofol is one of the most commonly used general anesthetics in surgery and is used as a sedative in the ICU for critical care patients (including those with COVID-19). It is used to initiate and maintain procedural sedation, general anesthesia, and so on. The US Food and Drug Administration approved the use of Fresenius Propoven 2% emulsion to maintain sedation in COVID-19 patients (16 years and older) requiring mechanical ventilation in June 2020.

How Does Anesthesia Work?

Depending on the procedure and type of anesthesia required, your healthcare provider may administer the anesthesia in the following ways:

  • Inhaled gas.
  • Injection, including intravenous or shots.
  • Topical liquid, spray, or patch (applied to the skin or eyes).

Influencers Fueling The Market Growth

An Increasing Number Of Surgeries, A Geriatric Population, And Technological Advancements Are Expected To Drive Market Growth.

The increase in the number of surgeries that use anesthetics during the surgical procedure is one of the major factors driving the Anesthetics Market. An increase in surgeries is primarily due to an increase in traumatic injuries and accidents that necessitate surgical procedures. According to the World Health Organization's Global Status Report on Road Safety 2018, 1.35 million road accidents occur each year, with 64 deaths per 100,000 vehicles.

Furthermore, technological advancements in drug delivery, the development of specifically targeted treatments, the development of equipment to monitor patients’ physiological characteristics during and after anesthetics, and reduced anesthetic side effects are driving factors that will boost market growth. According to the United Nations Department of Economic and Social Affairs, one in every four people in Europe and Northern America could be 65 or older by 2050. Chronic diseases such as cardiovascular and neurological diseases are on the rise in older populations, further increasing the demand for Anesthesia Drugs.

Customize this study as per your requirement @

Hurdles Faced During The Market Growth

Lack Of Infrastructure, Lack Of Awareness, And The High Cost Of Drugs And Procedures Are Limiting The Market Growth.

The lack of healthcare institutions in underdeveloped countries and remote areas, in addition to the lack of Anesthesia doctors and certified Anesthesia nurses per capita, is expected to be a restraint on the growth of the Anesthesia Drugs market. Furthermore, high prices for procedures and branded drugs will suppress market growth during the forecast period. A lack of Anesthesia awareness among the general public is another factor affecting the anesthesia drugs market.

After-surgery Impacts of Anesthesia Drugs Recovery time is critical after surgery because the patient may suffer irreversible physical damage. As a result, patients are kept under clinical observation until they regain consciousness.

Vomiting, nausea, irregular heart rhythm, body temperature, respiratory rate, sore throat, and respiratory system irritation are just a few of the major drawbacks associated with general Anesthesia Drugs that have a negative impact on the market.

One Of The Major Challenges In The Anesthesia Market Is Unintentional Intraoperative Awareness.

Furthermore, when General Anesthesia is administered during the surgical procedure, approximately one or two people out of every 1000 may be unaware that they are partially awake. There is very little chance of experiencing pain, but it is possible. Because people are given relaxation drugs prior to surgery, they are unable to move or communicate their pain or consciousness to the doctors. There is a chance that this will cause patients to experience long-term psychological problems, similar to post-traumatic stress disorder. This is known as unintentional intraoperative awareness, and it is one of the most significant challenges facing the Anesthesia market.

Covid 19's Impact on the Global Anesthesia Drugs Market

As a result of the pandemic, which caused surgery delays or cancellations, there was a slight decrease in demand for Anesthesia Drugs in 2020. According to a study published in the British Journal of Surgery, approximately 28.4 million elective surgeries were canceled or postponed worldwide in May 2020 due to hospital service disruption caused by COVID-19. Nonetheless, as social activities resume, all postponed surgeries are now being performed, implying that Anesthesia Drugs are being consumed in greater quantities, resulting in the anesthesia drugs Market gradually resuming market growth.

The entire healthcare and medical sector saw a significant increase in revenue, which benefited the anesthesia drugs market. Furthermore, rising healthcare expenditure and advanced medical infrastructure are expected to drive market growth in the coming years. Consumers are also spending more on healthcare, and private entities are increasing their investments in drug development. As a result, even in the coming years, the COVID-19 pandemic is expected to have a long-term positive impact on the global general anesthesia drugs market.

General Anesthesia Drugs- The Dominator In The Global Anesthesia Drugs Market By Type

Since they helped doctors create personalized anesthesia plans that balance the patient's history with the anticipated surgical plan, General anesthesia drugs dominated the market due to the increasing number of major surgeries around the world.

General Surgeries - The Dominator In The Global Anesthesia Drugs Market By Application

Anesthetics are widely used in surgical procedures hence general surgery dominated the market. The market is expected to expand significantly over the forecasted period. The market is being driven by an increase in the number of surgeries, an aging population with an increase in the number of chronic diseases, and technological advancements in anesthesia.

Intravenous - The Dominator In The Global Anesthesia Drugs Market By Route of Administration

Intravenous drugs dominated the anesthesia drugs market because they provide numerous benefits such as more accurate dosing, improved patient safety, lower rates of postoperative nausea, vomiting, urinary retention, and malignant hyperthermia (a rare but serious side effect of general anesthesia), and a lower risk of blood clots and pulmonary emboli (blood clots that move to the lungs).

North America - The Dominator In The Global Anesthesia Drugs Market By Region

Each year, North America perceives a significant increase in surgical procedures. Cancer, heart disease, and cardiovascular disease are all common in this region, and they are on the rise. Due to the prevalence of these surgeries, there are numerous growth opportunities in this market. Forecasts for the US Anesthesia Drugs market show a strong increase, which will contribute to the growth of the North America anesthesia drugs market.

Because of the influence of social media influencers, there is currently a market trend for looking fit. This has resulted in an increase in the number of people wanting to change their bodies, resulting in an increase in the number of cosmetic or plastic surgeries. An increase in dental surgeries accounts for an increase in anesthesia drug demand. The risks associated with anesthesia act as a market limitation. In some cases, the use of anesthesia necessitates additional precautions. The use of general anesthesia in children and pregnant women, in particular, requires authorization.

What Effect Does Anesthesia Have On Pregnancy?

A small area of the body is affected by Local Anesthesia. It is thought to be safe for pregnant or breastfeeding women. During childbirth, many pregnant women can safely receive Regional Anesthesia, such as an epidural or spinal block. Your doctor may advise you to postpone elective procedures that require regional or General Anesthesia until after childbirth.

What Effect Does Anesthesia Have On Breastfeeding?

Breastfeeding mothers and their infants are not at risk from anesthesia. All types of anesthesia, including General Anesthesia, use medications that leave the body quickly. It is frequently advised that patients express their first breast milk following a general anesthetic before resuming breastfeeding their newborn.

You can place an order or ask any questions, please feel free to contact us at 

The Number of Anesthesiologists Worldwide:

According to a survey conducted by the World Federation of Societies of Anesthesiologists, the number of Anesthesiologists worldwide has increased. They discovered that wealthy countries, such as the United States and Germany, have 20 to 30 Anesthesiologists for every 100,000 people, whereas Sub-Saharan Africa and parts of Asia have fewer than one for every 100,000 people. Switzerland has 54.22 per 100,000 people; the Russian Federation seems to have 20.91 per 100,000 people; the United States has 20.82 per 100,000 people; South Africa has 16.18 per 100,000 people; Canada has 12.42 per 100,000 people; Cuba has 15.68 per 100,000 people; Mexico has 6.42 per 100,000 people; China has 5.12 per 100,000 people; Namibia has 4.7 per 100,000 people; Thailand has 2.45 per 100,000 people; Peru has 1.76 per 100,000 people; Gabon has 1.28 per 100,000 people; India has 1.26 per 100,000 people;

Key Development:


  • Pacira BioSciences Inc.'s supplemental new drug application (sNDA) for the augmented use of Exparel (Bupivacaine Liposome Injectable Suspension) in pediatric patients was approved by the U.S. Food and Drug Administration in March 2021. The Food and Drug Administration (FDA).
  • In January 2020, the Food and Drug Administration approved a new drug application for Lannett Company's cocaine hydrochloride (HCI; NUMBRINO) nasal solution 4% (40 mg/mL) for anesthetic use in the United States.


  • PAION AG announced in June 2019 that The European Investment Bank would provide it with capital in the amount of approximately $20 million.


  • Hikma Pharmaceuticals PLC (Hikma) launched Bupivacaine HCl Injection USP in December 2021 through its US subsidiary Hikma Pharmaceuticals USA Inc. Doses of 10 mL and 30 mL are available.
  • Fresenius Kabi launch its first product with an RFID smart label in the United States on October 8, 2020. The anesthetic Diprivan® (Propofol) injection, which comes in a 20 mL bottle and uses radio frequency identification (RFID) technology, is the company's first smart-labeled product.


  • Medova and the New York School of Regional Anesthesia (NYSORA) will collaborate in June 2020 to launch SAFIRA (SAFer Injection for Regional Anesthesia) in the United States.

Related Reports

  • Antibodies Drug Market: The global antibodies drug market size reached USD 200.18 billion in 2022 and is expected to exceed USD 605.8 billion by 2032, expanding at a CAGR of 10.8% between 2023 and 2032.
  • AI in Drug Discovery Market: The global artificial intelligence in drug discovery market size was estimated at US$ 1,495.28 million in 2022 and is projected to hit around US$ 14,518.68 million by 2032, registering growth at a CAGR of 20.08% from 2022 to 2032.
  • Generic Drugs Market: The global generic drugs market size is estimated to grow from USD 439.37 billion in 2022 at 5.3% CAGR (2023-2032) to reach an estimated USD 738.53 billion by 2032.

Key Market Players

Baxter, Abbott Laboratories, Aspen Pharmacare, Fresenius Kabi AG, Roche, B. Braun Melsungen AG, AbbVie, Boehringer Ingelheim, Hikma Pharmaceuticals, and GlaxoSmithKline are the market leaders.

Unlocking Market Insights through Data Excellence 

The "Precedence Statistics" flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today's dynamic and data-driven world. 

Access our Premium Real Time Data Intelligence Tool, Visit:

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Browse our Brand-New Journal@

Browse our Consulting Website@

For Latest Update Follow Us: